Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
Clinical trial NCT04934527 · COMPLETED
Trial details
- NCT number
- NCT04934527
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2024-12-19
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.